Chairman, Department of Medicine

Nephrology

Mitchell Rosner practices Nephrology. He graduated from Medical College of Georgia School of Medicine. He has 31 awards "University of Virginia School of Medicine", "CMS Meaningful Use Stage 1 Certification", "Award for Basic Science Teaching Excellence", "Faculty Teacher of the Year", "Certificate of Appreciation: United States Department of State", "Named Honorary Staff Member", "Attending Physician of the Year", "Master Educator Award", "Selected to be the Banner Carrier for Graduation Ceremonies", "Selected for Class Marshall for Graduation", "Mentor of the Year Award", "Evergreen Award", "Selected to Participate in Teaching in Academic Medicine Inaugural Course", "Deans Award for Clinical Excellence", "Nominated, Teacher of the Year Award", "Award for Teaching Excellence", "Fellow (FACP)", "Fellow", "All-University of Virginia Teaching Award for Excellence in Teaching", "Elected to Membership in the Academy of Distinguished Educators", "Selected to Participate in the Leadership in Academic Medicine Course", "Deans Award for Excellence in Teaching", "Teaching Award", "All-University of Virginia Award for Best Teacher", "Alpha Omega Alpha Medical Honor Society", "First Place: Oral Case Presentation", "Research Scholarship", "American Heart Association Research Scholarship", "John Harvard Academic Scholarship", "Westinghouse Science Talent Search Award" and "Phi Beta Kappa". Mitchell H. Rosner is a published doctor and has 97 publications published. The lastest was: 'The ECG diagnosis of acute myocardial infarction in the presence of left bundle branch block.' He is registered with Medicare and accepts Medicare payments.

Publications

---

• Targeting Endogenous Repair Pathways after AKI.
• Statement of the 3rd International Exercise-Associated Hyponatremia Consensus Development Conference, Carlsbad, California, 2015.
• Inflammation in AKI: Current Understanding, Key Questions, and Knowledge Gaps.
• Therapeutic Targets of Human AKI: Harmonizing Human and Animal AKI.
• Progression after AKI: Understanding Maladaptive Repair Processes to Predict and Identify Therapeutic Treatments.
• Glomerular Diseases and cancer: evaluation of underlying malignancy.
• Emerging Therapeutic Targets of Sepsis-Associated Acute Kidney Injury.
• Wilderness medical society practice guidelines for treatment of exercise-associated hyponatremia: 2014 update.
• AKI Associated With Cardiac Surgery.
• Interpreting diagnostic tests in ESRD patients: an introduction.
• Indications and management of mechanical fluid removal in critical illness.
• The Use of a Tablet Computer Platform to Optimize the Care of Patients Receiving Peritoneal Dialysis: A Pilot Study.
• Techniques for the Assessment of Volume Status in Patients with End Stage Renal Disease.
• Training the Next Generation's Nephrology Workforce.
• New Insights into the Determinants of the Serum Sodium and Risk for Dysnatremias.
• Pre-procedural Bioimpedance Vectorial Analysis of fluid status and prediction of Contrast-Induced Acute Kidney Injury.
• The Podocyte Under Stress: AKT2 to the Rescue.
• Cancer and the Kidney: The Growth of Onco-nephrology.
• Electrolyte Disorders associated with cancer.
• Chronic Kidney disease in patients with renal cell carcinoma.
• In reply to Clinical practice guidelines for treatment of exercise-associated hyponatremia.
• Wilderness Medical Society practice guidelines for treatment of exercise-associated hyponatremia.
• Approach to Diagnosis and Treatment of Hypercalcemia in a Patient With Malignancy.
• Acute kidney injury in the elderly.
• The changing demographics of the global population predict that the number of people age 65 years or greater will triple over the coming decades. Introduction.
• Cost of peritoneal dialysis and hemodialysis across the world.
• Chronic Kidney disease: old outcomes and new answers.
• Assessment of intravascular volume status and volume responsiveness in critically ill patients.
• Lixivaptan: a vasopressin receptor antagonist for the treatment of hyponatremia.
• Prevention of postoperative Acute kidney injury: one step closer.
• Onco-Nephrology: What the Nephrologist Needs to Know about Cancer and the Kidney.
• Onco-Nephrology: The Pathophysiology and Treatment of Malignancy-Associated Hypercalcemia.
• Acute kidney injury and residual renal function.
• Ocular Problems in the Patient with End-Stage Renal Disease.
• Remote monitoring for continuous peritoneal dialysis.
• Dialysis modality choice for the elderly patient with end-stage renal Disease.
• Neutrophil gelatinase-associated lipocalin in the early diagnosis of peritonitis: the case of neutrophil gelatinase-associated lipocalin.
• The role of inflammation in the cardio-Renal syndrome: a focus on cytokines and inflammatory mediators.
• Ferumoxytol for the treatment of Iron deficiency.
• B-type natriuretic Peptide in the critically ill with Acute kidney injury.
• The cardioRenal syndrome.
• Computerized decision support systems: improving patient safety in nephrology.
• The future nephrology workforce: will there be one?
• Remote monitoring for the wearable artificial Kidney.
• Hyponatremia and congestive heart Failure: a marker of increased mortality and a target for therapy.
• Proteinuria in a patient with Diabetes.
• Intravenous iron therapy and risk for progressive loss of Kidney function in patients with chronic Kidney disease.
• Vancomycin-related eosinophilic peritonitis.
• Acute kidney injury in elderly intensive care patients: a review.
• Hyponatremia in heart Failure: the role of arginine vasopressin and its antagonism.
• Osmotic demyelination syndrome.
• Geriatric nephrology: responding to a growing challenge.
• Epidemiology of Acute kidney injury.
• Dysnatremias in the intensive care unit.
• Acute kidney injury in the elderly: a review.
• Oliguria, creatinine and other biomarkers of Acute kidney injury.
• Pretransplant predictors of recovery of Renal function after liver transplantation.
• Development, implementation, and results of the ASN in-training examination for fellows.
• Care of the undocumented immigrant in the United States With ESRD.
• Acute kidney injury: turning the tide.
• Acute kidney injury.
• Ferumoxytol for the treatment of anemia in chronic Kidney disease.
• Variability in Calcium, phosphorus, and parathyroid hormone in patients on hemodialysis.
• Hyponatremia in heart Failure: the role of arginine vasopressin and diuretics.
• The pathogenesis of susceptibility to Acute kidney injury in the elderly.
• Exercise-associated hyponatremia.
• Case report: exercise-associated hyponatremia With rhabdomyolysis during endurance exercise.
• Urinary biomarkers for the detection of Renal injury.
• The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) and the Kidney.
• The mortality risk associated With higher hemoglobin: is the therapy to blame?
• Glucose in the dialysate: historical perspective and possible implications?
• Statement of the Second International Exercise-Associated Hyponatremia Consensus Development Conference, New Zealand, 2007.
• Urinary biomarkers as a diagnostic tool for Acute kidney injury.
• Cardiac surgery as a cause of Acute kidney injury: pathogenesis and potential therapies.
• Outcomes for hepatorenal syndrome and Acute kidney injury in patients undergoing liver transplantation: a single-center experience.
• Pharmacologic treatment of Acute kidney injury: why drugs haven't worked and what is on the horizon.
• Measuring risk in end-stage renal Disease: is N-terminal pro brain natriuretic peptide a useful marker?
• Risk factors for symptomatic hyponatraemia: the role of pre-existing asymptomatic hyponatraemia.
• Acute kidney dysfunction secondary to the abdominal compartment syndrome.
• Management of lipid abnormalities associated with end-stage renal Disease.
• Acute renal failure caused by renal infiltration by hematolymphoid malignancy.
• Cromolyn sodium: a potential therapy for uremic pruritus?
• Renal function testing.
• Management of cirrhotic ascites: physiological basis of diuretic action.
• Lipid abnormalities associated with end-stage renal Disease.
• Acute kidney injury associated with cardiac surgery.
• Hemodialysis for the non-nephrologist.
• Natriuretic peptides in ESRD.
• Ocular abnormalities associated with advanced Kidney disease and hemodialysis.
• Severe hyponatremia associated With the combined use of thiazide diuretics and selective serotonin reuptake inhibitors.
• Combination therapy with angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in the treatment of patients with type 2 Diabetes mellitus.
• Renovascular Hypertension: can we identify a population at high risk?
• Pseudohypertension in a patient With diffuse scleroderma.
• Electrocardiography in the patient With the Wolff-Parkinson-White syndrome: diagnostic and initial therapeutic issues.
• The ECG diagnosis of Acute myocardial infarction in the presence of left bundle branch block.
• Lixivaptan - an evidence-based review of its clinical potential in the treatment of hyponatremia.

Schools

---

• Medical College of Georgia

• University Of Va

• University Of Va School Of Med

Procedures Preformed

---

• Hemodialysis
• Peritoneal Dialysis

Conditions Treated

---

• Acidosis
• Acute Glomerulonephritis
• Acute Kidney Failure
• Alkalosis
• View All

Doctors Specialties

---

• Nephrology

Accepted Insurances

---

Awards

---

• University of Virginia School of Medicine
• CMS Meaningful Use Stage 1 Certification
• Award for Basic Science Teaching Excellence
• Faculty Teacher of the Year
• Certificate of Appreciation: United States Department of State
• Named “Honorary Staff Member”
• Attending Physician of the Year
• Master Educator Award
• Selected to be the “Banner Carrier” for Graduation Ceremonies
• Selected for Class Marshall for Graduation
• Mentor of the Year Award
• Evergreen Award
• Selected to Participate in “Teaching in Academic Medicine” Inaugural Course
• Dean’s Award for Clinical Excellence
• Nominated, Teacher of the Year Award
• Award for Teaching Excellence
• Fellow (FACP)
• Fellow
• All-University of Virginia Teaching Award for Excellence in Teaching
• Elected to Membership in the Academy of Distinguished Educators
• Selected to Participate in the Leadership in Academic Medicine Course
• Dean’s Award for Excellence in Teaching
• Teaching Award
• All-University of Virginia Award for Best Teacher
• Alpha Omega Alpha Medical Honor Society
• First Place: Oral Case Presentation
• Research Scholarship
• American Heart Association Research Scholarship
• John Harvard Academic Scholarship
• Westinghouse Science Talent Search Award
• Phi Beta Kappa

Education

---

• University of Virginia
• Medical College of Georgia School of Medicine
• Harvard University

Hospital

---

• University of Virginia Medical Center

Drug Facts

---

NPI NUMBER		1164591707
NPPES Provider LastName		ROSNER
NPPES Provider FirstName		MITCHELL
NPPES Provider ZIPCode		229080001
NPPES Provider State		VA
Specialty Description		Nephrology
Total Claim Count		827.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1164591707
Last Name Of The Provider	ROSNER
First Name Of The Provider	MITCHELL
View All

Similar Doctors

---

	Dr. David G. Bains, MD This Doctor is OpenDoctor Recommended.
	Dr. Bed P. Chhatkuli, MD This Doctor is OpenDoctor Recommended.
	Dr. Uta Erdbruegger, MD This Doctor is OpenDoctor Recommended.
	Dr. Joshua D. King, MD
	Dr. Peter I. Lobo, MD This Doctor is OpenDoctor Recommended.
	Dr. Jwalant R. Patel, MD This Doctor is OpenDoctor Recommended.
	Dr. Hans E. Yehnert, MD This Doctor is OpenDoctor Recommended.
	Dr. James R. Freeman, MD This Doctor is OpenDoctor Recommended.
	Dr. Thu H. Le, MD
	Dr. Thurein Kyaw, MD
	Dr. Mary O. Muoneke, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog